-
Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients
HOVON89 study group, Mar 2025, In: Haematologica. 110, 3, p. 772-776 5 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Validation of the diagnostic potential of 17 immunophenotypic core markers defined by the ELN-iMDS-Flow Working Group in an independent cohort of patients with MDS
Veenstra, C. R., Alhan, C., Westers, T. M. & van de Loosdrecht, A. A., Mar 2025, In: HemaSphere. 9, 3, e70075.Research output: Contribution to journal › Article › Academic › peer-review
-
High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidine
Tiso, F., in 't Hout, F. E. M., Knops, R., Kroeze, L. I., van Rooij, A., van de Loosdrecht, A. A., Westers, T. M., Langemeijer, S. M. C., Preudhomme, C., Duployez, N., Fenaux, P., Kosmider, O., Bouscary, D., de Graaf, A. O., Martens, J. H. A., van der Reijden, B. A., Adès, L., Fontenay, M. & Jansen, J. H., 1 Jan 2025, In: HemaSphere. 9, 1, e70034.Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications
